Cargando…
Covid-19: pharmacotherapeutic insights on various curative approaches in terms of vulnerability, comorbidities, and vaccination
A novel coronavirus disease (COVID-19), caused by a severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), was discovered in Wuhan, China, in December 2019, and the world has suffered from a pandemic. As of 22nd March 2020, at least 185 countries worldwide had been affected by COVID-19. SARS-...
Autores principales: | Kaur, Rupinder, Singh, Shareen, Singh, Thakur Gurjeet, Sood, Pragati, Robert, Jiki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8722419/ https://www.ncbi.nlm.nih.gov/pubmed/34981320 http://dx.doi.org/10.1007/s10787-021-00904-w |
Ejemplares similares
-
Role of Nuclear Factor Kappa B (NF-KB) Signalling in Neurodegenerative Diseases: An Mechanistic Approach
por: Singh, Shareen, et al.
Publicado: (2020) -
Pharmacotherapeutics Applications and Chemistry of Chalcone Derivatives
por: Dhaliwal, Jagjit Singh, et al.
Publicado: (2022) -
An Insight into Potential Pharmacotherapeutic Agents for Painful Diabetic Neuropathy
por: Qureshi, Zunaira, et al.
Publicado: (2022) -
Pharmacotherapeutic Options for Visceral Leishmaniasis—Current Scenario
por: Pandey, Krishna, et al.
Publicado: (2009) -
Interactive Effects of Serum Leptin Levels and Physical Comorbidity on the Pharmacotherapeutic Response of Depressive Disorders
por: Choi, Wonsuk, et al.
Publicado: (2022)